Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.
Saved in:
| Title: | Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results. |
|---|---|
| Authors: | Regillo C; Wills Eye Hospital, Thomas Jefferson University, Mid Atlantic Retina, Philadelphia, Pennsylvania. Electronic address: Cregillo@midatlanticretina.com., Berger B; Austin Clinical Research, Austin, Texas., Brooks L; Southern Vitreoretinal Associates, Tallahassee, Florida., Clark WL; Palmetto Retina Center, Columbia, South Carolina., Mittra R; Retina Consultants of Minnesota, Minneapolis, Minnesota., Wykoff CC; Retina Consultants of Texas, Houston, Texas., Callaway NF; Genentech, Inc., South San Francisco, California; Stanford University Byers Eye Institute, Palo Alto, California., DeGraaf S; Genentech, Inc., South San Francisco, California., Ding HT; Genentech, Inc., South San Francisco, California., Fung AE; Genentech, Inc., South San Francisco, California., Gune S; Genentech, Inc., South San Francisco, California., Le Pogam S; Genentech, Inc., South San Francisco, California., Smith R; Genentech, Inc., South San Francisco, California., Willis JR; Genentech, Inc., South San Francisco, California., Barteselli G; Genentech, Inc., South San Francisco, California. |
| Source: | Ophthalmology [Ophthalmology] 2023 Jul; Vol. 130 (7), pp. 735-747. Date of Electronic Publication: 2023 Mar 02. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
